Frontotemporal dementia: genes and variants
Explore variant evidence for Frontotemporal dementia across 3 analyzed proteins (PSEN1, MAPT, GRN). Linked ClinVar records include 80 pathogenic or likely pathogenic variants, 141 variants of uncertain significance and 28 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Frontotemporal dementia
PSEN1: Presenilin-1
Its catalytic activity within gamma-secretase cleaves APP and many other membrane proteins, including Notch receptors. Pathogenic variants alter amyloid-beta production and are the most common known cause of autosomal dominant early-onset Alzheimer disease.
63 ClinVar pathogenic / likely pathogenic and 62 uncertain variants in PSEN1 have source records linked to Frontotemporal dementia. Association strength is not clinical gene validity.
MAPT: Microtubule-associated protein tau
Its tau isoforms stabilize and organize neuronal microtubules, especially in axons, while also participating in transport and signaling. Pathogenic variants cause inherited frontotemporal dementia, and abnormal tau aggregation defines multiple neurodegenerative tauopathies.
17 ClinVar pathogenic / likely pathogenic and 105 uncertain variants in MAPT have source records linked to Frontotemporal dementia. Association strength is not clinical gene validity.
GRN: Progranulin
It is secreted and proteolytically processed into granulins and has roles in lysosomal function, inflammation, neuronal survival, and tissue repair. Heterozygous loss-of-function variants cause frontotemporal dementia through progranulin haploinsufficiency, while biallelic loss causes neuronal ceroid lipofuscinosis.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GRN have source records linked to Frontotemporal dementia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SETX, CSF1R and OPTN.
Where Frontotemporal dementia variants cluster
- PSEN1 Transmembrane (positions 249–272): 11 of 61 ClinVar pathogenic / likely pathogenic variants, 3.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Frontotemporal dementia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PSEN1 M146L | 146 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 G206A | 206 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L262F | 262 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L262V | 262 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 P267T | 267 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 P267L | 267 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 R269H | 269 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 E280G | 280 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| MAPT P618L | 618 | Tau/MAP 2 | Pathogenic / likely pathogenic (★★) |
| MAPT P618S | 618 | Tau/MAP 2 | Pathogenic / likely pathogenic (★★) |
| PSEN1 T116N | 116 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PSEN1 P117L | 117 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PSEN1 N135S | 135 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 M146I | 146 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 G206D | 206 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 R269G | 269 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L392V | 392 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 A79V | 79 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PSEN1 T119I | 119 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PSEN1 V261I | 261 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 P264L | 264 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MAPT G652S | 652 | Tau/MAP 3 | Pathogenic / likely pathogenic (★★) |
| MAPT V654M | 654 | Tau/MAP 4 | Pathogenic / likely pathogenic (★★) |
| PSEN1 L85P | 85 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L113P | 113 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PSEN1 Y115C | 115 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PSEN1 I143T | 143 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 S212Y | 212 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 I249L | 249 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L271V | 271 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MAPT Q653H | 653 | Tau/MAP 3 | Pathogenic / likely pathogenic (★★) |
| PSEN1 A246E | 246 | Lumenal | Pathogenic / likely pathogenic (★★) |
| MAPT N596K | 596 | Tau/MAP 2 | Pathogenic / likely pathogenic (★★) |
| MAPT G706R | 706 | Pathogenic / likely pathogenic (★★) | |
| PSEN1 C92S | 92 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 S169L | 169 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 F177S | 177 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 G217R | 217 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PSEN1 M233V | 233 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 A285V | 285 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PSEN1 L381F | 381 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 L418F | 418 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PSEN1 A426P | 426 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MAPT L583V | 583 | Tau/MAP 1 | Pathogenic / likely pathogenic (★★) |
| MAPT R723W | 723 | Pathogenic / likely pathogenic (★★) | |
| PSEN1 M139V | 139 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MAPT G329R | 329 | Pathogenic / likely pathogenic (★★) | |
| PSEN1 H163R | 163 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PSEN1 M84I | 84 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 M84V | 84 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 T116I | 116 | Lumenal | Pathogenic / likely pathogenic (★) |
| PSEN1 P117S | 117 | Lumenal | Pathogenic / likely pathogenic (★) |
| PSEN1 N135D | 135 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 G209E | 209 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 G209V | 209 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 E280K | 280 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| PSEN1 E280A | 280 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| PSEN1 L392P | 392 | Transmembrane | Pathogenic / likely pathogenic (★) |
| PSEN1 A260V | 260 | Transmembrane | Pathogenic / likely pathogenic (★) |
| MAPT P681S | 681 | Tau/MAP 4 | Pathogenic / likely pathogenic (★) |
Showing 60 of 80.
Uncertain variants prioritized for review in Frontotemporal dementia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PSEN1 A260G | 260 | Transmembrane | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; A260V at the same position is pathogenic; REVEL 0.966 |
Which prediction tools work for Frontotemporal dementia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- AlphaMissense: 97 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 92 out of 100
- EVE: 90 out of 100
- phyloP: 90 out of 100
- SIFT: 86 out of 100
- SpliceAI: 62 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 43 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Alzheimer disease also has ClinVar records linked to PSEN1 variants; they fall in the same places as the Frontotemporal dementia variants (88 pathogenic / likely pathogenic).
- Pick disease also has ClinVar records linked to PSEN1 variants; they fall in the same places as the Frontotemporal dementia variants (26 pathogenic / likely pathogenic).
- Supranuclear palsy, progressive, 1 also has ClinVar records linked to MAPT variants; they fall partly in the same places as the Frontotemporal dementia variants (6 pathogenic / likely pathogenic).
Diseases related to Frontotemporal dementia
- Alzheimer disease, also linked to GRN, MAPT and PSEN1
- Pick disease, also linked to MAPT and PSEN1
- Dementia, also linked to GRN and PSEN1
- Hereditary hemorrhagic telangiectasia, also linked to PSEN1
- Dilated cardiomyopathy, also linked to PSEN1
- Familial acne inversa, also linked to PSEN1
- Neuronal ceroid lipofuscinosis, also linked to GRN
- Parkinson disease, also linked to MAPT
- Supranuclear palsy, progressive, 1, also linked to MAPT
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, also linked to GRN
- Familial isolated dilated cardiomyopathy, also linked to PSEN1
- Autosomal dominant Alzheimer disease, also linked to PSEN1
Frequently asked questions
Which genes have records linked to Frontotemporal dementia?
This view contains 3 analyzed proteins: PSEN1, MAPT, GRN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 80 pathogenic or likely pathogenic variants, 141 variants of uncertain significance and 28 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 283 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center